Kopin Corporation (KOPN) SEC Filings & Earnings Calls
EquiReason read 15 Kopin Corporation SEC filings in the last 12 months. Latest: 10-Q on 2026-08-11 — Kopin reported Q2 2026 revenue up 50.6% YoY and returned to profitability with net income of $0.8M, driven by defense sales, R&D contracts, and government grants..
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
- Market cap
- 628.2M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 3 Nov, in 10 days
Every filing, read
last 12 months · SECWhat happened, the numbers inside, guidance and risks. The original is one click away.
11 Aug 202610-QKopin reported Q2 2026 revenue up 50.6% YoY and returned to profitability with net income of $0.8M, driven by defense sales, R&D contracts, and government grants.earningsopen
Figures in the filing · each found in the filing text
| Total Revenue · Q2-2026 | $13M | +51% y/y |
| Net Income (Loss) · Q2-2026 | $800000.00 | |
| Defense Product Revenue · Defense · Q2-2026 | $7M | +18% y/y |
| R&D Revenue · Q2-2026 | $2M | +139% y/y |
| Grant Revenue · Q2-2026 | $3M | |
| Cost of Product Revenues as % of Net Product Revenues · Q2-2026 | 86.0% | |
| Cash and Cash Equivalents (excl. restricted) · Q2-2026 | $25M |
Guidance
Capex guided $5.0M-$6.5M for H2 2026; liquidity expected into Q4 2027
Management expects sufficient liquidity into Q4 2027 and plans capex of $5-6.5M in H2 2026, indicating confidence in continued operations.
Risks flagged
Litigation liability from BlueRadios case
“The Company has posted a bond to satisfy the court’s verdict of $19.7 million in damages and anticipated accrued interest in the matter of BlueRadios vs. Kopin Corporation, Inc. should the Company’s appeal be unsuccessful.” · word for word
Cash burn and going concern risk
“We had net income of $0.8 million and a net loss of $2.9 million for the three and six months ended June 27, 2026 and a net loss of $2.6 million in fiscal year 2025, and net cash outflows used in operations of $5.1 million and $15.5 million for the six months ended June 27, 2026 and for the fiscal year ended 2025, respectively.” · word for word
Industrial segment decline
“Industrial applications revenues represent customers who purchase our display products for use in headsets used for manufacturing, distribution, public safety, 3D metrology equipment and other industrial applications. ... we expect this trend will continue and hence we are focusing our product and selling efforts on other more attractive market segments.” · word for word
10 Aug 20268-K · 2.02Total Revenues $13M (+51% y/y); Product Revenues $8M (+2% y/y); Non-Product Revenues $5M (+433% y/y); Guidance: Exceeding prior guidance; optimistic about 2027earningsopen
Figures in the filing · each found in the filing text
| Total Revenues · Q2-2026 | $13M | +51% y/y |
| Product Revenues · Q2-2026 | $8M | +2% y/y |
| Non-Product Revenues · Q2-2026 | $5M | +433% y/y |
| Cost of Product Revenues · Q2-2026 | $7M | -7% y/y |
| R&D Expenses · Q2-2026 | $5M | +133% y/y |
| SG&A Expenses · Q2-2026 | $5M | +5% y/y |
Guidance
Exceeding prior guidance; optimistic about 2027
CFO explicitly states expectation to exceed prior guidance; strong demand signals for Sentinel FPV and MicroLED.
Risks flagged
Dependence on U.S. government contracts and program awards; R&D spending increasing significantly.
“R&D Expenses increased 133% YoY; revenue heavily tied to government programs.”
18 Jun 20268-K · 7.01Kopin entered share repurchase agreements with Lightning Silicon Technology and LS Assets, repurchasing 18M shares each for $1.00, cancelling them. Also terminated a Technology License Agreement and Services Agreement, with mutual releasesopen
Risks flagged
Loss of equity interest in LST and LSA may indicate reduced strategic alignment or future revenue from those entities.
“Kopin no longer holds any equity interest in either LST or LSA.” · word for word
4 Jun 20268-K · 8.01Disclosed a material event under other events (litigation, recall, contract loss, or major announcement)open
Risks flagged
Share dilution from preferred stock conversion.
“Conversion of all Series A Convertible Preferred Stock into common shares.”
12 May 202610-QTotal Revenue $11M (+0% y/y); Net Loss $-4M; Defense Product Revenue $5M (-37% y/y)open
Figures in the filing · each found in the filing text
| Total Revenue · Q1-2026 | $11M | +0% y/y |
| Net Loss · Q1-2026 | $-4M | |
| Defense Product Revenue · Q1-2026 | $5M | -37% y/y |
| Grant Revenue · Q1-2026 | $3M | |
| Collaboration Revenue · Q1-2026 | $330000.00 | |
| R&D Expense · Q1-2026 | $5M | +132% y/y |
| Cash and Cash Equivalents · Q1-2026 | $60M | |
| Operating Cash Flow · Q1-2026 | $-810746.00 | |
| Cost of Product Revenues as % of Net Product Revenues · Q1-2026 | 103.0% |
Risks flagged
Negative Product Gross Margin
“Cost of product revenues as a % of net product revenues 103% for the three months ended March 28, 2026 compared to 83% for the three months ended March 29, 2025.” · word for word
Litigation Liability
“the Company has posted a bond to satisfy the court’s verdict of $19.7 million in damages and anticipated accrued interest in the matter of BlueRadios vs. Kopin Corporation, Inc.” · word for word
Defense Revenue Concentration Decline
“Defense $5,310 for the three months ended March 28, 2026 compared to $8,461 for the three months ended March 29, 2025.”
Cash Runway Limited
“We estimate we will have sufficient liquidity to fund operations into the third quarter of 2027.” · word for word
12 May 20268-K · 2.02Total Revenues $11M (+1% y/y); Product Revenues $5M (-41% y/y); Non-Product Revenues $5M (+292% y/y)earningsopen
Figures in the filing · each found in the filing text
| Total Revenues · Q1-2026 | $11M | +1% y/y |
| Product Revenues · Q1-2026 | $5M | -41% y/y |
| Non-Product Revenues · Q1-2026 | $5M | +292% y/y |
| Cost of Product Revenues · Q1-2026 | $6M | -26% y/y |
| R&D Expenses · Q1-2026 | $5M | +133% y/y |
| SG&A Expenses · Q1-2026 | $6M | +28% y/y |
Risks flagged
Product revenue decline of 41% YoY due to lower thermal weapon sight shipments
“Product revenues declined from $9.2M to $5.4M”
R&D spend increased 133% YoY, potentially pressuring near-term profitability
“R&D Expenses $4.9 million, up 133%”
22 Apr 2026DEF 14AAnnual proxy statement (DEF 14A) filed, detailing executive compensation, governance, and a proposal to increase the equity incentive plan share reserve by 6 million shares.open
Figures in the filing · each found in the filing text
| Orders · FY2025 | $61M | |
| Net Income (Loss) · FY2025 | $3M | |
| Total Shareholder Return (Cumulative $100 Investment) · FY2025 | $188.71 |
Risks flagged
Customer Concentration / Dependence on Defense Contracts
“A significant portion of Kopin’s revenues is derived from the sale of our products for defense applications” · word for word
Execution Risk on Strategic Transformation
“In 2025, we continued the reorganization of Kopin under a program we call One Kopin.” · word for word
Share Dilution from Equity Compensation
“The Amended Plan authorizes the issuance or transfer of up to 6,000,000 shares of our common stock with respect to awards granted under the Amended Plan on and after the Restatement Effective Date.”
13 Apr 202610-KTotal Revenues $39M (-22% y/y); Defense Revenue $29M (-29% y/y); Industrial Revenue $3M (+38% y/y); Guidance: No formal revenue guidance; expects funded R&D to increase in FY2026open
Figures in the filing · each found in the filing text
| Total Revenues · FY2025 | $39M | -22% y/y |
| Defense Revenue · Defense · FY2025 | $29M | -29% y/y |
| Industrial Revenue · Industrial · FY2025 | $3M | +38% y/y |
| Medical Revenue · Medical · FY2025 | $594000.00 | +477% y/y |
| R&D Revenue · R&D · FY2025 | $5M | -24% y/y |
| Cost of Product Revenues as % of Net Product Revenues · FY2025 | 84.2% | |
| Cash and Marketable Securities · FY2025 | $62M | +68% y/y |
| Net Income (Loss) · FY2025 | $3M | +106% y/y |
Guidance
No formal revenue guidance; expects funded R&D to increase in FY2026
Management expects funded R&D to increase in FY2026 due to new contracts, but no formal revenue guidance provided. Backlog strength from MicroLED orders.
Risks flagged
Customer Concentration
“DRS Network & Imaging Systems LLC comprising 63% of revenues in 2025 and therefore posing a concentration risk.” · word for word
Litigation Liability
“On September 5, 2025, Kopin received a judgment from the courts in the BlueRadios litigation awarding BlueRadios $19.7 million in damages.” · word for word
Supply Chain Disruption
“We have identified several semiconductor components which continue to have long delivery times.” · word for word
27 Mar 20268-K · 2.02Total Revenues $8M (-42% y/y); Product Revenues $6M (-56% y/y); Non-Product Revenues $2M (+47% y/y)earningsopen
Figures in the filing · each found in the filing text
| Total Revenues · Q4-2025 | $8M | -42% y/y |
| Product Revenues · Q4-2025 | $6M | -56% y/y |
| Non-Product Revenues · Q4-2025 | $3M | +47% y/y |
| Cost of Product Revenues · Q4-2025 | $5M | -56% y/y |
| R&D Expenses · Q4-2025 | $4M | +13% y/y |
| SG&A Expenses · Q4-2025 | $5M | +45% y/y |
Risks flagged
Government shutdown and procurement delays impacting revenue recognition and order flow.
“government shutdown and associated procurement delays which impacted timing of expected program orders, product shipments and contract activity during the quarter” · word for word
9 Jan 20268-K · 5.02Reported a director or officer change (departure, election, appointment or pay arrangement)open
Risks flagged
Equity grants dilute existing shareholders; options have 25% premium exercise price.
“583,658 restricted shares and 724,638 options granted to CEO; 72,000 restricted shares to COO.”
12 Nov 20258-K · 2.02Total revenues $12M (-10% y/y); Product revenues $11M (-2% y/y); Net income $4Mearningsopen
Figures in the filing · each found in the filing text
| Total revenues · Q3-2025 | $12M | -10% y/y |
| Product revenues · Q3-2025 | $11M | -2% y/y |
| Net income · Q3-2025 | $4M | |
| Earnings per share · Q3-2025 | $0.02 | |
| Cash and cash equivalents · Q3-2025 | $26M | |
| Cost of product revenues · Q3-2025 | $8M | +1% y/y |
| Research and development expenses · Q3-2025 | $3M | -4% y/y |
| SG&A expenses · Q3-2025 | $2M | -69% y/y |
Risks flagged
Revenue decline YoY; reliance on defense contracts
“Total revenues decreased to $12.0M from $13.3M; product revenues down slightly”
12 Nov 202510-QKopin reported Q3 2025 net income of $4.1M vs loss of $3.5M in prior year, driven by litigation damages reversal and improved operating income.earningsopen
Figures in the filing · each found in the filing text
| Total revenues · Q3-2025 | $12M | -10% y/y |
| Net income (loss) · Q3-2025 | $4M | |
| Contract assets · 2025-09-27 | $10M | |
| Remaining performance obligations · 2025-09-27 | $39M | |
| Cash and cash equivalents · 2025-09-27 | $27M |
Risks flagged
Litigation liability
“Accrued litigation liability $19,700,000 at September 27, 2025.”
Revenue decline
“Total revenues decreased 10.2% year-over-year in Q3 2025.”
Kopin Corporation — questions
- What did Kopin Corporation file recently?
- 15 SEC filings in the last 12 months. Latest: 10-Q on 2026-08-11 — Kopin reported Q2 2026 revenue up 50.6% YoY and returned to profitability with net income of $0.8M, driven by defense sales, R&D contracts, and government grants.
Every figure on this page comes from Kopin Corporation's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.